TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis

Cell Death Dis. 2024 Nov 13;15(11):821. doi: 10.1038/s41419-024-07223-2.

Abstract

Angiogenesis is well known to play a critical role in breast cancer. We previously reported that TNFAIP2 activates Rac1 to promote triple-negative breast cancer (TNBC) cell proliferation, migration, and chemoresistance. However, the potential contribution of TNFAIP2 to tumor angiogenesis remains unknown. In this study, we demonstrated that TNFAIP2 promotes TNBC angiogenesis by activating the Rac1-ERK-AP1-HIF1α signaling axis. Under hypoxia, TNFAIP2 activates Rac1 and ERK sequentially. Following that, ERK activates the AP-1 (c-Jun/Fra1) transcription factor. By employing chromatin immunoprecipitation and luciferase reporter assays, we showed that AP-1 directly interacts with the HIF1α gene promoter, thereby enhancing its transcription. The combined application of ERK inhibitors, U0126 or trametinib, with the VEGFR inhibitor Apatinib, additively suppresses angiogenesis and tumor growth of HCC1806 in nude mice. These findings provide new therapeutic strategies for TNBC.

MeSH terms

  • Angiogenesis
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit* / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit* / metabolism
  • MAP Kinase Signaling System / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude*
  • Neovascularization, Pathologic* / genetics
  • Neovascularization, Pathologic* / metabolism
  • Neovascularization, Pathologic* / pathology
  • Nitriles / pharmacology
  • Pyridines / pharmacology
  • Pyridones / pharmacology
  • Pyrimidinones / pharmacology
  • Signal Transduction*
  • Transcription Factor AP-1 / metabolism
  • Transcription, Genetic / drug effects
  • Triple Negative Breast Neoplasms* / drug therapy
  • Triple Negative Breast Neoplasms* / genetics
  • Triple Negative Breast Neoplasms* / metabolism
  • Triple Negative Breast Neoplasms* / pathology
  • rac1 GTP-Binding Protein* / genetics
  • rac1 GTP-Binding Protein* / metabolism

Substances

  • Hypoxia-Inducible Factor 1, alpha Subunit
  • rac1 GTP-Binding Protein
  • HIF1A protein, human
  • RAC1 protein, human
  • Transcription Factor AP-1
  • Pyrimidinones
  • Pyridines
  • apatinib
  • trametinib
  • Pyridones
  • Extracellular Signal-Regulated MAP Kinases
  • Nitriles